- Home
- CREV vs EVOK Comparison
CREV vs EVOK Comparison
Compare CREV & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- EVOK
- Stock Information
- Founded
- CREV 2007
- EVOK 2007
- Country
- CREV Ireland
- EVOK United States
- Employees
- CREV N/A
- EVOK N/A
- Industry
- CREV
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- EVOK Health Care
- Exchange
- CREV Nasdaq
- EVOK Nasdaq
- Market Cap
- CREV 6.0M
- EVOK 5.4M
- IPO Year
- CREV N/A
- EVOK 2013
- Fundamental
- Price
- CREV $4.16
- EVOK $5.21
- Analyst Decision
- CREV
- EVOK
- Analyst Count
- CREV 0
- EVOK 0
- Target Price
- CREV N/A
- EVOK N/A
- AVG Volume (30 Days)
- CREV 57.1K
- EVOK 437.4K
- Earning Date
- CREV 05-14-2025
- EVOK 08-14-2025
- Dividend Yield
- CREV N/A
- EVOK N/A
- EPS Growth
- CREV N/A
- EVOK N/A
- EPS
- CREV N/A
- EVOK N/A
- Revenue
- CREV $39,261,077.00
- EVOK $12,794,859.00
- Revenue This Year
- CREV $40.76
- EVOK $57.38
- Revenue Next Year
- CREV $86.18
- EVOK $59.57
- P/E Ratio
- CREV N/A
- EVOK N/A
- Revenue Growth
- CREV 41.52
- EVOK 70.02
- 52 Week Low
- CREV $2.00
- EVOK $1.94
- 52 Week High
- CREV $12.75
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- CREV 48.40
- EVOK 50.12
- Support Level
- CREV $3.72
- EVOK $5.03
- Resistance Level
- CREV $5.02
- EVOK $5.57
- Average True Range (ATR)
- CREV 0.38
- EVOK 0.44
- MACD
- CREV -0.04
- EVOK -0.09
- Stochastic Oscillator
- CREV 33.85
- EVOK 11.17
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.